FHND1002

· Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FHND1002, covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: FHND1002 for ALS Treatment: Phase 2 [Phase 2]